A Knowledge, Attitudes and Practices Survey Conducted Three Years after Halting Ivermectin Mass Treatment for Onchocerciasis in Guatemala.

A Knowledge, Attitudes and Practices Survey Conducted Three Years after Halting Ivermectin Mass Treatment for Onchocerciasis in Guatemala.

BACKGROUND:Mass drug administration (MDA) with ivermectin for onchocerciasis was provided in Guatemala's Central Endemic Zone (CEZ) over a 24 year period (1988-2011). Elimination of Onchocerca volvulus transmission was declared in 2015 after a three year post MDA surveillance period (2012-2014)...

Full description

Bibliographic Details
Main Authors:	Frank O Richards, Robert E Klein, Oscar de León, Renata Mendizábal-Cabrera, Alba Lucía Morales, Vitaliano Cama, Carol G Crovella, Carlos E Díaz Espinoza, Zoraida Morales, Mauricio Sauerbrey, Nidia Rizzo
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-06-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	http://europepmc.org/articles/PMC4920414?pdf=render

Similar Items

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
by: Nana O Wilson, et al.
Published: (2016-12-01)

Elimination of onchocerciasis in Africa by 2025: the need for a broad perspective
by: Ed Cupp, et al.
Published: (2019-07-01)

Molecular epidemiology of emerging ivermectin resistance in onchocerciasis
by: Osei-Atweneboana, Mike Yaw, 1966-
Published: (2008)

Importance of ivermectin to human onchocerciasis: past, present, and the future
by: Cupp EW, et al.
Published: (2011-05-01)

Modelling the impact of mass administration of ivermectin in the treatment of onchocerciasis (river blindness)
by: E.O. Omondi, et al.
Published: (2018-01-01)

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
by: Achille S Nikièma, et al.
Published: (2021-03-01)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019-08-01)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
by: Fanny Nadia Dissak-Delon, et al.
Published: (2017-08-01)

Compliance with eight years of annual ivermectin treatment of onchocerciasis in Cameroon and Nigeria
by: Elhassan Elizabeth, et al.
Published: (2011-07-01)

Immunity in onchocerciasis after ivermectin prophylaxis : studies with Onchocerca ochengi in cattle
by: Njongmeta, Leo Moh
Published: (2002)

Elimination of African onchocerciasis: modeling the impact of increasing the frequency of ivermectin mass treatment.
by: Luc E Coffeng, et al.
Published: (2014-01-01)

Sustainable control of onchocerciasis: ocular pathology in onchocerciasis patients treated annually with ivermectin for 23 years: a cohort study.
by: Méba Banla, et al.
Published: (2014-01-01)

Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.
by: Hugo C Turner, et al.
Published: (2013-01-01)

Impact of long-term treatment of onchocerciasis with ivermectin in Ecuador: potential for elimination of infection
by: Proaño Roberto, et al.
Published: (2007-05-01)

Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution.
by: Raquel Lovato, et al.
Published: (2014-05-01)

Onchocerciasis in the Americas: from arrival to (near) elimination
by: Sauerbrey Mauricio, et al.
Published: (2011-10-01)

Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone
by: Joseph B. Koroma, et al.
Published: (2018-04-01)

Factors associated with compliance with community directed treatment with ivermectin for onchocerciasis control in Southwestern Ethiopia
by: Wondafrash Mekite, et al.
Published: (2010-06-01)

Impact of Six Years Community Directed Treatment with Ivermectin in the Control of Onchocerciasis, Western Ethiopia.
by: Abdi Samuel, et al.
Published: (2016-01-01)

Impacts of ivermectin mass drug administration for onchocerciasis on mosquito populations of Ogun state, Nigeria
by: Olaitan Olamide Omitola, et al.
Published: (2021-04-01)

Drawing and interpreting data: Children's impressions of onchocerciasis and community-directed treatment with ivermectin (CDTI) in four onchocerciasis endemic countries in Africa
by: Mary Amuyunzu-Nyamongo, et al.
Published: (2011-05-01)

Adverse reactions from community directed treatment with ivermectin (CDTI ) for onchocerciasis and loiasis in Ondo State, Nigeria
by: O.A Otubanjo, et al.
Published: (2008-12-01)

Successful interruption of transmission of Onchocerca volvulus in the Escuintla-Guatemala focus, Guatemala.
by: Rodrigo J Gonzalez, et al.
Published: (2009-01-01)

Impact of long-term treatment of onchocerciasis with ivermectin in Kaduna State, Nigeria: first evidence of the potential for elimination in the operational area of the African Programme for Onchocerciasis Control
by: Tekle Afework, et al.
Published: (2012-02-01)

Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador.
by: Mariella Anselmi, et al.
Published: (2015-11-01)

Seroprevalence of onchocerciasis in Ogun State, Nigeria after ten years of mass drug administration with ivermectin
by: O. A. Surakat, et al.
Published: (2018-09-01)

The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon.
by: Raphael Awah Abong, et al.
Published: (2021-01-01)

Audit of the community-directed treatment with ivermectin (CDTI) for onchocerciasis and factors associated with adherence in three regions of Cameroon
by: Guy-Roger Kamga, et al.
Published: (2018-06-01)

Assessment of the performance of community-directed treatment with ivermectin strategy for the control and elimination of onchocerciasis in Edo State, Nigeria
by: Amenze Oritsemofe Onowhakpor, et al.
Published: (2017-01-01)

Fifteen Years of Annual Mass Treatment of Onchocerciasis with Ivermectin Have Not Interrupted Transmission in the West Region of Cameroon
by: Moses N. Katabarwa, et al.
Published: (2013-01-01)

The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study.
by: Hugo C Turner, et al.
Published: (2013-01-01)

Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.
by: Kathrin Arndts, et al.
Published: (2014-02-01)

African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases.
by: Stanimira P Krotneva, et al.
Published: (2015-01-01)

Why onchocerciasis transmission persists after 15 annual ivermectin mass drug administrations in South-West Cameroon
by: Armelle Forrer, et al.
Published: (2021-01-01)

Single versus multiple dose ivermectin regimen in onchocerciasis-infected persons with epilepsy: A randomized clinical trial
by: M. Mandro, et al.
Published: (2020-12-01)

Comparison of some immunological parameters between untreated and ivermectin-treated onchocerciasis patients in the Nkwanta North District of Ghana
by: J. Labadah, et al.
Published: (2020-12-01)

Prevalence of onchocerciasis and associated clinical manifestations in selected hypoendemic communities in Ghana following long-term administration of ivermectin
by: Kenneth Bentum Otabil, et al.
Published: (2019-05-01)

Determinants of community-led ivermectin treatment adherence for onchocerciasis control in Western Ethiopia: a case-control study
by: Fikadu Ayalew, et al.
Published: (2020-04-01)

Impact of 19 years of mass drug administration with ivermectin on epilepsy burden in a hyperendemic onchocerciasis area in Cameroon
by: Charlotte Boullé, et al.
Published: (2019-03-01)

Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
by: Lamine Diawara, et al.
Published: (2009-07-01)